HC Wainwright reissued their buy rating on shares of Phio Pharmaceuticals (NASDAQ:PHIO – Free Report) in a report published on Wednesday morning, Marketbeat reports. They currently have a $6.00 target price on the stock. HC Wainwright also issued estimates for Phio Pharmaceuticals’ Q3 2023 earnings at ($1.43) EPS, Q4 2023 earnings at ($0.81) EPS, FY2023 […]
Phio Pharmaceuticals Corp. (NASDAQ:PHIO – Get Free Report) was the target of a significant drop in short interest in June. As of June 30th, there was short interest totalling 25,400 shares, a drop of 71.9% from the June 15th total of 90,300 shares. Approximately 1.7% of the company’s stock are sold short. Based on an […]
Phio Pharmaceuticals Corp. (NASDAQ:PHIO – Get Rating)’s share price rose 0.3% during mid-day trading on Monday . The stock traded as high as $4.15 and last traded at $3.99. Approximately 17,227 shares were traded during trading, a decline of 84% from the average daily volume of 106,256 shares. The stock had previously closed at $3.98. […]